Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
QNCX
QNCX News & Events
-
Add to Watchlist
Trade QNCX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
QNCX News
Quince's Clinical Trial Fails to Meet Key Endpoints
12 hours ago
stocktwits
Quince Therapeutics Reports Phase 3 Trial Results for A-T Treatment
14 hours ago
Businesswire
Quince Therapeutics' Clinical Trial Fails to Meet Primary Endpoint
14 hours ago
Newsfilter
Quince Completes A-T Phase 3 Trial, Expects Results in Q1 2026
Dec 15 2025
Newsfilter
Quince Therapeutics Publishes eDSP Clinical Study Results, Showcasing Broad Application Potential
Dec 10 2025
Newsfilter
Monday's Underperforming Sectors: Biotechnology, Electronic Equipment, and Products
Dec 01 2025
NASDAQ.COM
Quince Therapeutics to Hold Virtual Investor Day on October 2, 2025
Sep 11 2025
Newsfilter
This Lionsgate Studios Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Aug 05 2025
Benzinga
Show More News
QNCX Events
01/29 15:40
Shares Drop 88% to 39c After Company Halts eDSP Clinical Development
Shares have fallen $2.79, or 88%, to 39c in afternoon trading after the company said it will cease clinical development of eDSP.
Show More Events
QNCX Monitor News
Quince Therapeutics' Clinical Trial Fails, Stock Drops Significantly
Jan 29 2026
QNCX Earnings Analysis
No Data
People Also Watch
